share_log

Hims & Hers Health | 8-K: Current report

Hims & Hers Health | 8-K: Current report

Hims & Hers Health | 8-K：重大事件
美股SEC公告 ·  2024/06/11 04:45

Moomoo AI 已提取核心訊息

Hims & Hers Health held its Annual Meeting of Stockholders on June 6, 2024, where shareholders voted on three key proposals. All eight nominated directors, including CEO Andrew Dudum and medical experts Dr. Patrick Carroll and Dr. Delos Cosgrove, were successfully elected to serve until the 2025 annual meeting.Stockholders overwhelmingly approved the appointment of KPMG LLP as the company's independent registered public accounting firm for fiscal year 2024, with 1.59 billion votes in favor. Additionally, shareholders provided advisory approval for the company's executive compensation package, receiving 1.51 billion supporting votes.The voting process involved both Class A Common Stock (one vote per share) and Class V Common Stock (175 votes per share) holders, with a total of 206,271,215 Class A shares and 8,377,623 Class V shares eligible to vote as of the April 16, 2024 record date.
Hims & Hers Health held its Annual Meeting of Stockholders on June 6, 2024, where shareholders voted on three key proposals. All eight nominated directors, including CEO Andrew Dudum and medical experts Dr. Patrick Carroll and Dr. Delos Cosgrove, were successfully elected to serve until the 2025 annual meeting.Stockholders overwhelmingly approved the appointment of KPMG LLP as the company's independent registered public accounting firm for fiscal year 2024, with 1.59 billion votes in favor. Additionally, shareholders provided advisory approval for the company's executive compensation package, receiving 1.51 billion supporting votes.The voting process involved both Class A Common Stock (one vote per share) and Class V Common Stock (175 votes per share) holders, with a total of 206,271,215 Class A shares and 8,377,623 Class V shares eligible to vote as of the April 16, 2024 record date.
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    樸荷生物科技
    PHH
    -- 13.480
    雷特控股
    RAY
    -- 1.140
    Hims & Hers Health
    HIMS
    -- 34.750
    海倫特洛伊家電
    HELE
    -- 52.850
    e.l.f. Beauty
    ELF
    -- 62.850
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    中概股財報季火熱：驚喜盈利能否延續漲勢？
    1. 哪些行業可能成為本輪財報季的市場焦點？ 2. 在政府強調科技創新和可持續發展的背景下，你認為哪些行業具有最大的增長潜力？ 展开
    中國兩會：會議前後股票價格變動的關鍵要點